ArticleMolecular cancer therapeutics2016

Dual Agonist Surrobody Simultaneously Activates Death Receptors DR4 and DR5 to Induce Cancer Cell Death.

Snezana Milutinovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.